Cancer Drug for Alzheimer's Treatment Mooresville NC

New research suggests that a cancer drug might be able to restore day-to-day memory in patients with Alzheimer's disease. The disease, the most common form of dementia among the elderly, is expected to afflict 120 million people worldwide by 2050. Often the first sign is loss of short-term memory.

Andrew Joseph Braunstein
(704) 662-3077
124 Professional Park Dr
Mooresville, NC
Specialty
Neurology

Data Provided by:
Trishwant Singh Garcha, MD
(704) 872-8711
Mooresville, NC
Specialties
Neurology
Gender
Male
Education
Medical School: Howard Univ Coll Of Med, Washington Dc 20059
Graduation Year: 1991

Data Provided by:
Craig Danl Dubois, MD
(704) 662-3077
124 Professional Park Dr Ste A
Mooresville, NC
Specialties
Neurology
Gender
Male
Education
Medical School: Oh State Univ Coll Of Med, Columbus Oh 43210
Graduation Year: 1990

Data Provided by:
Mark Richard Ippolito, MD
(704) 262-1911
Davidson, NC
Specialties
Neurology
Gender
Male
Education
Medical School: Suny At Buffalo Sch Of Med & Biomedical Sci, Buffalo Ny 14214
Graduation Year: 1992

Data Provided by:
Lori Beth Schneider, MD
(704) 896-5591
19615 Liverpool Pkwy Ste A
Cornelius, NC
Specialties
Neurology
Gender
Female
Education
Medical School: New York Univ Sch Of Med, New York Ny 10016
Graduation Year: 1990

Data Provided by:
Craig Daniel DuBois
(704) 662-3077
124 Professional Park Dr
Mooresville, NC
Specialty
Neurology

Data Provided by:
Peterson Giallanza
(704) 662-3077
124 Professional Park Dr
Mooresville, NC
Specialty
Neurology

Data Provided by:
Jeffrey S Yablon
(704) 799-3206
134 Medical Park Rd
Mooresville, NC
Specialty
Neurosurgery

Data Provided by:
Russ Adam Bodner, MD
Davidson, NC
Specialties
Neurology
Gender
Male
Education
Medical School: Med Coll Of Pa, Philadelphia Pa 19129
Graduation Year: 1990

Data Provided by:
Joseph William Markey, MD
(704) 343-0696
18716 W Catawba Ave Ste 300
Cornelius, NC
Specialties
Neurology
Gender
Male
Education
Medical School: Univ Of Cincinnati Coll Of Med, Cincinnati Oh 45267
Graduation Year: 1955

Data Provided by:
Data Provided by:

Cancer Drug for Alzheimer's Treatment

Provided By:

TUESDAY, Sept. 8 (HealthDay News) -- New research suggests that a cancer drug might be able to restore day-to-day memory in patients with Alzheimer's disease.

The disease, the most common form of dementia among the elderly, is expected to afflict 120 million people worldwide by 2050. Often the first sign is loss of short-term memory.

"People often joke that they must have Alzheimer's because they can't remember where they put their keys, but for a person with the disease, this type of short-term memory loss is extremely debilitating," study author Ottavio Arancio, an associate professor of pathology and cell biology at Columbia University Medical Center, said in a news release.

The researchers examined a cancer drug from a family of compounds called HDAC inhibitors. The drug tinkers with DNA, and in the mice the researchers studied it appeared to make it easier for neurons in the brain to manufacture new proteins.

That process is critical in the process of recording new memories.

"Because this type of drug has already been approved for some cancer patients, we hope that clinical trials for Alzheimer's disease can start in about three to four years," said co-author Mauro Fa, an associate research scientist at Columbia.

The findings appear in the September issue of the Journal of Alzheimer's Disease.

More information

Learn more about memory from McGill University.

SOURCE: Columbia University, news release, Sept. 3, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com